Correlation of platelet function with recurrent ischemic vascular events in stroke patients

被引:0
作者
Li, Zhenguang [1 ]
Zhang, Jiangshan [1 ]
Zhang, Jinbiao [1 ]
Sun, Hairong [1 ]
Li, Yan [1 ]
Wang, Pengfei [1 ]
Cong, Yannan [1 ]
机构
[1] Binzhou Med Coll, Affiliated Hosp, Weihai Municipal Hosp, Dept Neurol, 70 Heping St, Weihai 264200, Shandong, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2017年 / 10卷 / 04期
关键词
Stroke; ischemic event; aspirin; platelet function; risk factor; ASPIRIN RESISTANCE; LACUNAR STROKE; CLOPIDOGREL; INHIBITION; THERAPY; RISK;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Platelet activation and aggregation, as well as thrombosis, play an important role in the pathological and physiological processes of recurrent ischemic vascular events in stroke patients. The purpose of this study is to investigate the correlation of platelet function and recurrent ischemic vascular events in the secondary prevention of stroke. A total of 350 stroke patients within 72 h of onset from September 2014 to April 2015 were included in this study. The patients were administered aspirin starting from the day of admission. After 7-10 days, the platelet aggregation ratio was detected using method with continuous platelet counting, and the baseline data were recorded. The patients underwent a 6-month follow-up period, and the recurrent ischemic vascular events were observed. Logistic regression analysis was performed to obtain the risk factors for recurrent ischemic vascular events and the receiver operating characteristic (ROC) curve. The predictive value of the platelet aggregation ratio by method with continuous platelet counting detection for ischemic vascular events was analyzed. Among the 350 stroke patients, 52 patients had recurrent ischemic vascular events during the follow-up period. The proportion of the patients with recurrent ischemic events who also had diabetes (48.01% vs. 23.15%, P<0.001), low-density lipoprotein (LDL) cholesterol (3.02+/-0.74 vs. 2.74+/-0.72, P=0.016), an arachidonic acid-induced maximum platelet aggregation ratio (MAR-AA) (27.31+/-9.49 vs. 18.85+/-6.60, P<0.001), and an epinephrine-induced maximum platelet aggregation ratio (MAR-EPI) (61.26+/-13.02 vs. 51.41+/- 14.81, P<0.001) was significantly higher than that of the patients in the no ischemic vascular event group. These increased parameters were determined to be the independent risk factors for the occurrence of ischemic vascular events in stroke patients. MAR-AA was most closely related to the occurrence of ischemic vascular events (OR=1.133, 95% CI: 1.080+/-1.188, P<0.001) and showed a good predictive value for ischemic events with an area under the ROC curve (AUC) of 0.803. The increase in MAR-AA was also an independent risk factor for stroke recurrence (OR=1.090, 95% CI: 1.037+/-1.145, P=0.001). In the secondary prevention of stroke, platelet function measured with the continuous platelet counting method is closely related to recurrent ischemic vascular events; thus, this parameter has a good predictive value for recurrent ischemic vascular events.
引用
收藏
页码:6917 / 6925
页数:9
相关论文
共 20 条
  • [1] FAILURE OF ASPIRIN TREATMENT AFTER STROKE
    BORNSTEIN, NM
    KAREPOV, VG
    ARONOVICH, BD
    GORBULEV, AY
    TREVES, TA
    KORCZYN, AD
    [J]. STROKE, 1994, 25 (02) : 275 - 277
  • [2] Platelet Function Tests: A Review of Progresses in Clinical Application
    Choi, Jae-Lim
    Li, Shuhua
    Han, Jin-Yeong
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [3] Point-of-care assessment of platelet reactivity in the emergency department may facilitate rapid rule-out of acute coronary syndromes: a prospective cohort pilot feasibility study
    Darling, Chad E.
    Sala Mercado, Javier A.
    Quiroga-Castro, Walter
    Tecco, Gabriel F.
    Zelaya, Felix R.
    Conci, Eduardo C.
    Sala, Jose P.
    Smith, Craig S.
    Michelson, Alan D.
    Whittaker, Peter
    Welch, Robert D.
    Przyklenk, Karin
    [J]. BMJ OPEN, 2014, 4 (01):
  • [4] C-Reactive Protein as a Prognostic Marker After Lacunar Stroke Levels of Inflammatory Markers in the Treatment of Stroke Study
    Elkind, Mitchell S. V.
    Luna, Jorge M.
    McClure, Leslie A.
    Zhang, Yu
    Coffey, Christopher S.
    Roldan, Ana
    Del Brutto, Oscar H.
    Javier Pretell, Edwin
    Pettigrew, L. Creed
    Meyer, Brett C.
    Tapia, Jorge
    White, Carole
    Benavente, Oscar R.
    [J]. STROKE, 2014, 45 (03) : 707 - 716
  • [5] Advances in Our Understanding of ''Resistance'' to Antiplatelet Agents for Prevention of Ischemic Stroke
    Gorelick, Philip B.
    Farooq, Andmuhammad U.
    [J]. STROKE RESEARCH AND TREATMENT, 2013, 2013
  • [6] Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
    Grundmann, K
    Jaschonek, K
    Kleine, B
    Dichgans, J
    Topka, H
    [J]. JOURNAL OF NEUROLOGY, 2003, 250 (01) : 63 - 66
  • [7] Comparison between a new platelet count drop method PL-11, light transmission aggregometry, VerifyNow aspirin system and thromboelastography for monitoring short-term aspirin effects in healthy individuals
    Guan, Jie
    Cong, Yulong
    Ren, Junwei
    Zhu, Yuan
    Li, Li
    Deng, Xinli
    Bai, Jie
    [J]. PLATELETS, 2015, 26 (01) : 25 - 30
  • [8] A new subtype classification of ischemic stroke based on treatment and etiologic mechanism
    Han, Sang Won
    Kim, Seo Hyun
    Lee, Jong Yun
    Chu, Chong Kyu
    Yang, Jae Hoon
    Shin, Ha Young
    Nam, Hyo Suk
    Lee, Byung In
    Heo, Ji Hoe
    [J]. EUROPEAN NEUROLOGY, 2007, 57 (02) : 96 - 102
  • [9] Predictors of Stroke Recurrence in Patients with Recent Lacunar Stroke and Response to Interventions According to Risk Status: Secondary Prevention of Small Subcortical Strokes Trial
    Hart, Robert G.
    Pearce, Lesly A.
    Bakheet, Majid F.
    Benavente, Oscar R.
    Conwit, Robin A.
    McClure, Leslie A.
    Talbert, Robert L.
    Anderson, David C.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (04) : 618 - 624
  • [10] Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement
    Hochholzer, Willibald
    Trenk, Dietmar
    Bestehorn, Hans-Peter
    Fischer, Benjamin
    Valina, Christian M.
    Ferenc, Miroslaw
    Gick, Michael
    Caputo, Angelika
    Buettner, Heinz Joachim
    Neumann, Franz-Josef
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (09) : 1742 - 1750